Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
5
United Sts Brent Oil Fd Lp Unit
BNO
US Stock MarketDetailed Quotes
Avalo Therapeutics (AVTX)
- 16.260
- +2.480+18.00%
Close May 5 16:00 ET
- 24.150
- +7.890+48.52%
Post 19:59 ET
434.38MMarket Cap-2.78P/E (TTM)
16.300High13.870Low4.66MVolume13.870Open13.780Prev Close106.00MTurnover19.72%Turnover RatioLossP/E (Static)26.71MShares20.72052wk High5.23P/B384.26MFloat Cap3.39052wk Low--Dividend TTM23.63MShs Float22031.712Historical High--Div Yield TTM17.63%Range %3.390Historical Low22.745Avg Price1Lot Size
Avalo Therapeutics (AVTX) Key Financial Indicators
AVTX Earnings per Share (EPS)
According to the latest financial report of Avalo Therapeutics, the latest earnings per share (TTM) for the company is -0.37. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
AVTX Free Cash Flow (FCF)
Interested in knowing about Avalo Therapeutics's free cash flow? The latest report shows it as -14.25M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
AVTX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Avalo Therapeutics shows that the company's current ratio is 8.14, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
AVTX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Avalo Therapeutics, the quick ratio is 7.60, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
AVTX Return on Equity (ROE)
Want to learn more about the financial health of Avalo Therapeutics? The latest ROE figure is -15.72%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
AVTX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Avalo Therapeutics, the total asset return on investment (ROA) is -11.36%.
Currency: USD
Quarterly
Loading...
AVTX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Avalo Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
AVTX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Avalo Therapeutics, the net profit margin is -23.25K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump announced on the morning of August 5th, Eastern Time, that based on requests from countries such as Pakistan and signific
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm